These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12362092)

  • 41. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 42. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus.
    Bennett C; Green S; Barr H; Bhandari P; Decaestecker J; Ragunath K; Singh R; Tawil A; Jankowski J
    Cochrane Database Syst Rev; 2010 May; (5):CD007334. PubMed ID: 20464752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?
    Sharma P; Wani S; Rastogi A
    Gastrointest Endosc; 2007 Sep; 66(3):469-74. PubMed ID: 17725936
    [No Abstract]   [Full Text] [Related]  

  • 44. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.
    Bennett C; Green S; DeCaestecker J; Almond M; Barr H; Bhandari P; Ragunath K; Singh R; Jankowski J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD007334. PubMed ID: 32442322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can endoscopic resection for Barrett's dysplasia and early cancer be curative?
    Friedland S; Triadafilopoulos G
    Ann N Y Acad Sci; 2018 Dec; 1434(1):54-58. PubMed ID: 29752721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?
    Dar MS; Goldblum JR; Rice TW; Falk GW
    Gut; 2003 Apr; 52(4):486-9. PubMed ID: 12631655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysplasia in Barrett's esophagus: limitations of current management strategies.
    Spechler SJ
    Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer.
    Fountoulakis A; Zafirellis KD; Dolan K; Dexter SP; Martin IG; Sue-Ling HM
    Br J Surg; 2004 Aug; 91(8):997-1003. PubMed ID: 15286961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer.
    Rajaram R; Hofstetter WL
    Thorac Surg Clin; 2018 Nov; 28(4):473-480. PubMed ID: 30268293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 2005; 17(4):320-5. PubMed ID: 16428038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced endoscopic therapeutics in Barrett's neoplasia: where are we now and where are we heading?
    Longcroft-Wheaton G; Bhandari P
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):543-5. PubMed ID: 25850665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
    Mayne GC; Bright T; Hussey DJ; Watson DI
    ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.
    Schmidt HM; Mohiuddin K; Bodnar AM; El Lakis M; Kaplan S; Irani S; Gan I; Ross A; Low DE
    Surg Endosc; 2016 Aug; 30(8):3391-401. PubMed ID: 26541725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endoscopic eradication therapy for Barrett's oesophagus: state of the art.
    Kolb JM; Wani S
    Curr Opin Gastroenterol; 2020 Jul; 36(4):351-358. PubMed ID: 32487852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.